BioStem Technologies, Inc. vs Celularity Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- BioStem Technologies, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 29, 2026 for BioStem Technologies, Inc. and Oct 30, 2026 for Celularity Inc.).
- BioStem Technologies, Inc. had more revenue: $47 M against $27 M for Celularity Inc., both in the year to December 2025.
- Both made a net loss: $7 M for BioStem Technologies, Inc. and $92 M for Celularity Inc.
- BioStem Technologies, Inc. keeps more of each dollar of sales: a net margin of -13.9% against -345.5% for Celularity Inc.
- BioStem Technologies, Inc.'s revenue grew faster in its latest fiscal year: -31.8% against -51.0% for Celularity Inc.
- Their Altman Z-scores put BioStem Technologies, Inc. in the grey zone and Celularity Inc. in the distress zone.
Market value, the same start = 100
From Jan 2022: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | BioStem Technologies, Inc. BSEM · #23,187 in the world | Celularity Inc. CELU · #23,307 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $29 M | $28 M |
| Revenue | $47 M | $27 M |
| Net income | $-7 M▲ best | $-92 M |
| Employees | — | 288 |
| Valuation | ||
| Price to sales | 0.7× | 1.5× |
| Price to book | 0.7× | — |
| Free cash flow yield | 22.8%▲ best | -23.8% |
| Profitability | ||
| Gross margin | 93.6%▲ best | 24.4% |
| Operating margin | -1.4%▲ best | -230.9% |
| Net margin | -13.9%▲ best | -345.5% |
| Return on equity | -16.6% | — |
| Growth | ||
| Revenue growth | -31.8%▲ best | -51.0% |
| Revenue growth, 3 years a year | — | 13.9% |
| Financial strength | ||
| Debt to equity | 0.0× | — |
| Cash | ||
| Free cash flow margin | 13.9% | — |
| Strength scores | ||
| Piotroski F-score | 5 of 9 | — |
| Altman Z-score zone | grey | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, BioStem Technologies, Inc. or Celularity Inc.?
BioStem Technologies, Inc. is the larger company by market value: $29 M against $28 M for Celularity Inc., 1.1 times as much (market caps of Oct 29, 2026 for BioStem Technologies, Inc. and Oct 30, 2026 for Celularity Inc.).
Which makes more money, BioStem Technologies, Inc. or Celularity Inc.?
BioStem Technologies, Inc. had more revenue: $47 M against $27 M for Celularity Inc., both in the year to December 2025. Both made a net loss: $7 M for BioStem Technologies, Inc. and $92 M for Celularity Inc.
Which is more profitable, BioStem Technologies, Inc. or Celularity Inc.?
BioStem Technologies, Inc. keeps more of each dollar of sales: a net margin of -13.9% against -345.5% for Celularity Inc.
Which is growing faster, BioStem Technologies, Inc. or Celularity Inc.?
BioStem Technologies, Inc.'s revenue grew faster in its latest fiscal year: -31.8% against -51.0% for Celularity Inc.
Which is financially stronger, BioStem Technologies, Inc. or Celularity Inc.?
Their Altman Z-scores put BioStem Technologies, Inc. in the grey zone and Celularity Inc. in the distress zone.
More about BioStem Technologies, Inc.
More about Celularity Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.